You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Labetalol Hydrochloride In Sodium Chloride patents expire, and what generic alternatives are available?

Labetalol Hydrochloride In Sodium Chloride is a drug marketed by Hikma and is included in one NDA.

The generic ingredient in LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE is labetalol hydrochloride. There are fourteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the labetalol hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Labetalol Hydrochloride In Sodium Chloride

A generic version of LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE was approved as labetalol hydrochloride by HERITAGE PHARMA on August 3rd, 1998.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE?
  • What are the global sales for LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE?
  • What is Average Wholesale Price for LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE?
Summary for LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE
Drug patent expirations by year for LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE
Recent Clinical Trials for LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Boston Medical CenterPhase 4
Marshall UniversityPhase 2
Loma Linda UniversityN/A

See all LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE clinical trials

Pharmacology for LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE

US Patents and Regulatory Information for LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE labetalol hydrochloride SOLUTION;INTRAVENOUS 213330-002 Nov 9, 2020 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE labetalol hydrochloride SOLUTION;INTRAVENOUS 213330-003 Nov 9, 2020 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE labetalol hydrochloride SOLUTION;INTRAVENOUS 213330-004 Nov 9, 2020 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.